These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4447386)

  • 1. The inhibition of glucose-6-phosphate dehydrogenase activity by dithranol (anthralin), zinc ions and/or salicylic acid.
    Raab W; Gmeiner B
    Arch Dermatol Forsch; 1974; 251(2):87-94. PubMed ID: 4447386
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antipsoriatic effect of dithranol (anthralin). 1].
    Raab W
    Hautarzt; 1975 Sep; 26(9):452-5. PubMed ID: 1184389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activity studies of various serum enzymes in patients with psoriasis locally treated with dithranol].
    Debreczeni M; Balogh E; Tóth A
    Dermatol Monatsschr; 1978 Jul; 164(7):509-14. PubMed ID: 689227
    [No Abstract]   [Full Text] [Related]  

  • 4. [Glucose-6-phosphate dehydrogenase and topical antipsoriatics. A comparison of anthralin, anthralin-monoacetate, anthralin-diacetate, anthralin-triacetate and 6-hydroxy-2-oxobenzoxathiole (author's transl)].
    Raab W; Siber H
    Arch Dermatol Forsch; 1974; 249(2):179-89. PubMed ID: 4418435
    [No Abstract]   [Full Text] [Related]  

  • 5. The interaction of anthralin, salicylic acid and zinc oxide in pastes.
    Hulsebosch HJ; Ponec-Waelsch M
    Dermatologica; 1972; 144(5):287-93. PubMed ID: 4663601
    [No Abstract]   [Full Text] [Related]  

  • 6. Factors affecting the clearance of psoriasis with dithranol (anthralin).
    Comaish S; Smith J; Seville RH
    Br J Dermatol; 1971 Mar; 84(3):282-9. PubMed ID: 5572679
    [No Abstract]   [Full Text] [Related]  

  • 7. Further studies on the interaction between anthralin salicylic acid and zinc oxide in pastes.
    Ponec-Waelsch M; Hulsebosch HJ
    Arch Dermatol Forsch; 1974; 249(2):141-52. PubMed ID: 4420796
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of ultraviolet light, various temperatures, and zinc ions on anthralin (dithranol). Biochemical and chemical investigations.
    Raab WP; Gmeiner BM
    Dermatologica; 1975; 150(5):267-76. PubMed ID: 1183690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does UV-A potentiate 'short contact' dithranol therapy?
    Reshad H; Barth JH; Darley CR; Baker H
    Br J Dermatol; 1984 Aug; 111(2):155-8. PubMed ID: 6466557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glyceraldehydephosphate dehydrogenase and glucose-6-phosphate dehydrogenase activities in psoriasis and neurodermatitis and the effect of dithranol.
    Hammar H
    J Invest Dermatol; 1970 Feb; 54(2):121-5. PubMed ID: 5412727
    [No Abstract]   [Full Text] [Related]  

  • 11. [Senecioyldithranol and beta-carbethoxypropionyldithranol: synthesis and glucose-6-phosphate dehydrogenase inhibition of two new 10-acyl derivatives of the antipsoriatic, dithranol].
    Rychener M; Steiger W; Krebs A
    Pharm Acta Helv; 1988; 63(4-5):111-6. PubMed ID: 3222264
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dithranol-urea treatment of chronic psoriasis. A comparison of 0,1% dithranol + 17% urea with triamcinolone acetonite 0,1% and phototherapy (author's transl)].
    Ernst TM
    Z Hautkr; 1981 Sep; 56(18):1197-206. PubMed ID: 7293304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dithranol (anthralin) versus triacetoxyanthracene. Investigations in vitro.
    Raab W
    Br J Dermatol; 1976 Aug; 95(2):193-6. PubMed ID: 782506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of psoriasis using Cignolin (dihydroxyanthranol): CSP (Cignolin-Salicylic acid-Petrolatum) - treatment schedule from Cologne].
    Orfanos CE; Steigleder GK
    Z Hautkr; 1976 Jun; 51(12):473-80. PubMed ID: 952029
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of psoriasis with salicylic acid, tar and dithranol].
    Juhlin L
    Lakartidningen; 1979 Oct; 76(43):3758-9. PubMed ID: 529922
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences in half-side treatment with tar additive to cignolin-salicylic-acid-white-vaseline therapy of psoriasis vulgaris].
    Schulze HJ; Steigleder GK
    Z Hautkr; 1984 May; 59(10):654-6. PubMed ID: 6741204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of dithranol in psoriasis fulgaris. Cyto- and histochemical investigations].
    Braun-Falco O; Burg G; Schoefinius HH
    Arch Dermatol Forsch; 1971; 241(3):217-36. PubMed ID: 4398688
    [No Abstract]   [Full Text] [Related]  

  • 18. [10-Acyldithranol dimers; new derivatives of the antipsoriatic dithranol; synthesis, characterization and biochemical properties].
    Berset JD; Krebs A
    Pharm Acta Helv; 1990; 65(5-6):155-64. PubMed ID: 2371307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical studies on the chemotherapy of psoriasis].
    Schaefer H
    Arch Klin Exp Dermatol; 1970; 237(1):240-5. PubMed ID: 4392036
    [No Abstract]   [Full Text] [Related]  

  • 20. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone).
    Mustakallio KK; Brandt H
    Acta Derm Venereol; 1984; 64(1):63-6. PubMed ID: 6203285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.